Skip to main content
fbc logo
  • facebook-social
  • linkedin-social
  • Home
  • About
  • Practices
  • Practices
      • Arbitration & Mediation
      • Aviation & Maritime
      • Banking & Finance
      • Blockchain and Cryptocurrency
      • Capital Markets
      • Class Actions & Derivative Suits
      • Commercial
      • Competition & Antitrust
      • Cybersecurity, IT & Data Protection
      • East Asia Desk
      • Environmental
      • Family & Inheritance Law
      • Financial Regulation
      • FinTech
      • French Desk
      • Global Talent Mobility & Relocation
      • Hi-Tech, Technology & Venture Capital
      • Hotels & Tourism
      • Insolvency & Restructuring
      • Intellectual Property
      • Investment Funds
      • Labor & Employment
      • Life Sciences & Healthcare
      • Liquidation & Receivership
      • Litigation
      • Mergers & Acquisitions
      • Philanthropy
      • Planning & Zoning
      • Private Asset Management
      • Private Equity
      • Project Finance & Energy
      • Real Estate
      • Regulatory
      • Sports Law
      • Tax
      • Tax - Municipal Tax
      • Tech Litigation
      • Telecom & Media
      • Trade Associations
      • White Collar
  • Team
  • News
  • Community
  • Alumni
  • Careers
  • Contact
  • FBC Online
  • Accessibility
  • Subscribe

Representation of Bristol-Myers Squibb Company in its $12M Investment in Compugen Ltd.

By Raz Tepper & Sharon Rosen | Oct 2018 | Transaction

FBC represented Bristol-Myers Squibb Company (NYSE: BMY) in connection with its $12M equity investment in Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery.
The equity offering was made as a private placement of public equity (PIPE). The equity investment is being made in conjunction with a clinical trial collaboration entered into between Bristol-Myers Squibb’s and Compugen to evaluate the safety and tolerability of Compugen’s COM701, an investigational anti-PVRIG antibody, in combination with Bristol-Myers Squibb’s programmed death-1 (PD-1) immune checkpoint inhibitor Opdivo (nivolumab), in patients with advanced solid tumors.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

For press coverage, see here and here.

Search by

General Search

Practice Area

  • Arbitration & Mediation
  • Aviation & Maritime
  • Banking & Finance
  • Blockchain and Cryptocurrency
  • Capital Markets
  • Class Actions & Derivative Suits
  • Commercial
  • Competition & Antitrust
  • Cybersecurity, IT & Data Protection
  • East Asia Desk
  • Environmental
  • Family & Inheritance Law
  • Financial Regulation
  • FinTech
  • French Desk
  • Global Talent Mobility & Relocation
  • Hi-Tech, Technology & Venture Capital
  • Hotels & Tourism
  • Insolvency & Restructuring
  • Intellectual Property
  • Investment Funds
  • Labor & Employment
  • Life Sciences & Healthcare
  • Liquidation & Receivership
  • Litigation
  • Mergers & Acquisitions
  • Philanthropy
  • Planning & Zoning
  • Private Asset Management
  • Private Equity
  • Project Finance & Energy
  • Real Estate
  • Regulatory
  • Sports Law
  • Tax
  • Tax - Municipal Tax
  • Tech Litigation
  • Telecom & Media
  • Trade Associations
  • White Collar

Attorney

Date

  • Last Month
  • Last Six Months
  • Last Year

Publication Type

  • Transaction
  • Publication
  • Legal Update
  • Firm News
Clear Search
Israel Law Firm of the year by IFLR 1000 for 2020

Recent News & Publications

מעו”דכן מיסים – סיווגו של יחיד כ”תושב ישראל” – תזכיר חוק חדש – יולי 2025

נבקשם לעדכנכם כי ביום 2 ביולי, 2025, פירסם משרד האוצר את טיוטת תזכיר החוק לתיקון פקודת מס הכנסה (תיקון מס'...)(מקום מושבו של יחיד), התשפ"ה-2...

Noa Lev Goldstein & Yuval Peled & Adam Kadesh | Jul 2025

מעו”דכן מחלקת לקוחות פרטיים, ניהול הון משפחתי והעברות בין-דוריות בעסקים משפחתיים ומחלקת מיסים – חלוקת דיבידנד לשם ביצוע הסכמי חלוקה – יולי 2025

בעדכון לקוחות זה נסקור בפניכם החלטה שניתנה לאחרונה על ידי המחלקה המקצועית ברשות המיסים בעניין "חלוקת דיבידנד אגב חלוקת נכסי עזבון ראשונה" במ...

Shalom Hershkovitz & Noa Lev Goldstein & Shahar Lifshitz, Prof. | Jul 2025

מעו”דכן איכות סביבה וקיימות – הוראת ניהול בנקאי תקין 345 – יוני 2025

הוראת ניהול בנקאי תקין 345, שפורסמה ביוני 2024 ותיכנס לתוקף ביוני 2026, מהווה נקודת מפנה משמעותית ברגולציה הפיננסית בישראל. ההוראה מחייבת את...

Merav Tabib | Jun 2025
View all News >>
Practice Areas
    • Arbitration & Mediation
    • Aviation & Maritime
    • Banking & Finance
    • Blockchain and Cryptocurrency
    • Capital Markets
    • Class Actions & Derivative Suits
    • Commercial
    • Competition & Antitrust
    • Cybersecurity, IT & Data Protection
    • East Asia Desk
    • Environmental
    • Family & Inheritance Law
    • Financial Regulation
    • FinTech
    • French Desk
    • Global Talent Mobility & Relocation
    • Hi-Tech, Technology & Venture Capital
    • Hotels & Tourism
    • Insolvency & Restructuring
    • Intellectual Property
    • Investment Funds
    • Labor & Employment
    • Life Sciences & Healthcare
    • Liquidation & Receivership
    • Litigation
    • Mergers & Acquisitions
    • Philanthropy
    • Planning & Zoning
    • Private Asset Management
    • Private Equity
    • Project Finance & Energy
    • Real Estate
    • Regulatory
    • Sports Law
    • Tax
    • Tax - Municipal Tax
    • Tech Litigation
    • Telecom & Media
    • Trade Associations
    • White Collar
Attorneys by Practice
    • Arbitration & Mediation
    • Aviation & Maritime
    • Banking & Finance
    • Blockchain and Cryptocurrency
    • Capital Markets
    • Class Actions & Derivative Suits
    • Commercial
    • Competition & Antitrust
    • Cybersecurity, IT & Data Protection
    • East Asia Desk
    • Environmental
    • Family & Inheritance Law
    • Financial Regulation
    • FinTech
    • French Desk
    • Global Talent Mobility & Relocation
    • Hi-Tech, Technology & Venture Capital
    • Hotels & Tourism
    • Insolvency & Restructuring
    • Intellectual Property
    • Investment Funds
    • Labor & Employment
    • Life Sciences & Healthcare
    • Liquidation & Receivership
    • Litigation
    • Mergers & Acquisitions
    • Philanthropy
    • Planning & Zoning
    • Private Asset Management
    • Private Equity
    • Project Finance & Energy
    • Real Estate
    • Regulatory
    • Sports Law
    • Tax
    • Tax - Municipal Tax
    • Tech Litigation
    • Telecom & Media
    • Trade Associations
    • White Collar
Team Member by Name
All Rights Reserved, FBC&Co
Photography by Ofir Abe | Designed By Hastudeö | Developed By Beaverglobal